Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower in Wednesday's after-hours session after the company announced a proposed offering of its common stock.
Recursion Pharmaceuticals Inc(纳斯达克:RXRX)的股票在周三的盘后交易中下跌,该公司宣布拟发行其普通股的公开发行,募集资金规模为2亿美元。
What Happened: After the market close on Wednesday, Recursion said it intends to offer and sell $200 million worth of its common stock in an underwritten public offering. All of the shares are being offered by Recursion.
事件经过:周三收盘后,Recursion 表示其打算通过承销公开发行发行和销售价值2亿美元的普通股。所有股票均由Recursion提供。
The clinical-stage biotech company also said it plans to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares being offered.
这家临床阶段的生物技术公司还表示,计划授权承销商购买所发售股票的15%的期权,期限为30天。
Recursion had $296.3 million in cash and cash equivalents as of March 31.
截至3月31日,Recursion持有现金及现金等价物2.963亿美元。
The proposed offering comes just days after Recursion held its annual investor day in which NVIDIA Corp (NASDAQ:NVDA) CEO Jensen Huang made an appearance to discuss the role AI will play in drug discovery and development in the future.
该拟议发行计划在Recursion举办其年度投资者日几天后出炉,英伟达公司(纳斯达克:NVDA)首席执行官黄仁勋在会上出席,讨论人工智能在未来药物发现和开发中的角色。
Recursion has built one of the most powerful supercomputers in the biotech space with the help of Nvidia. The two companies announced a multi-year collaboration last year.
Recursion与英伟达的合作,使之成为生物技术领域内最强大的超级计算机之一。两家公司去年宣布了一项为期多年的合作。
Nvidia also reported investments in multiple companies, including Recursion, in a 13-F filing with the SEC earlier this year, which garnered investor attention and sparked a short-lived surge in Recursion stock.
此外,英伟达在今年早些时候提交给美国证券交易委员会的13F申报中也披露多个公司的投资,其中包括Recursion,引起了投资者的关注并导致Recursion 股票短暂上涨。
According to the filing, Recursion is Nvidia's second-largest investment after Arm Holdings.
根据申报,Recursion是英伟达收购 Arm Holdings 后的第二大投资。
RXRX Price Action: Recursion Pharmaceuticals shares were down 8.33% after hours at $8.04 at the time of publication, according to Benzinga Pro.
RXRX股价行情:据Benzinga Pro消息,当时Recursion Pharmaceuticals股票在盘后交易中下跌8.33%,报8.04美元。
Photo: Pixabay.
图片来源:Pixabay。